Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R2 Technologies
San Ramon, California, United States
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
R2 Technologies' Glacial® platform is FDA-cleared and commercially available for benign skin lesion removal, reduction of pain and swelling, and temporary inflammation reduction, showing high patient satisfaction and visible improvements in skin conditions over 1-2 months.
- Therapeutic areas
- ImmunologyDermatology
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
02
Partnerships
Huadong MedicinePansend Life SciencesBlossom InnovationsMassachusetts General Hospital
Beyond the preview
Go deeper on R2 Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on R2 Technologies.